Antagonists of integrin α(v)β3 inhibit retinal neovascularization in a murine model

Laboratory Investigation

Volumn 75, Issue 4, 1996, Pages 563-573

  Luna, Jose ^a   Tobe, Takao ^a   Mousa, Shaker A ^b   Reilly, Thomas M ^b   Campochiaro, Peter A ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b DUPONT COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRONECTIN; INTEGRIN; VITRONECTIN;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; CELL ADHESION; DIABETIC NEUROPATHY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RETINA ISCHEMIA; RETINA NEOVASCULARIZATION; THROMBOCYTE ADHESION;

ANIMALS; DIABETIC RETINOPATHY; DISEASE MODELS, ANIMAL; ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; OLIGOPEPTIDES; PEPTIDES, CYCLIC; RECEPTORS, VITRONECTIN; RETINAL NEOVASCULARIZATION; RETINAL VESSELS; UP-REGULATION;

EID: 0029859140     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Aiello L, Pierce E, Foley E, Takagi H, Chen H, Riddle L, Ferrara N, King G, and Smith L (1995). Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins. Proc Natl Acad Sci USA 92:10457-10461.
2. Barthel L and Raymond P (1990). Improved method for obtaining 3-μm cryosections for immunocytochemistry. J Histochem Cytochem 38:1838-1888.
3. 3 for angiogenesis. Science 264:569-571.
4. 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels. Cell 79:1157-1164.
5. Cheresh D (1987). Human endothelial cells synthesize and express an Arg-Gly-Asp-directed adhesion receptor involved in attachment to fibrinogen and von Willebrand factor. Proc Natl Acad Sci USA 84:6471-6475.
6. Cheresh D, Berliner S, Vicente V, and Ruggeri Z (1989). Recognition of distinct adhesive site on fibrinogen by related integrin on platelets and endothelial cells. Cell 58:945-953.
7. de Bustros S, Thompson J, Michels R, and Rice T (1987). Vitrectomy for progressive proliferative diabetic retinopathy. Arch Ophthalmol 105:196-199.
8. The Diabetic Retinopathy Study Research Group (1981). Photocogulation treatment of proliferative diabetic retinopathy: Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. Ophthalmology 88:583-600.
9. Flynn H, Chew E, Simons B, Barton F, Remaley N, and Ferris F (1992). Pars plana vitrectomy in the Early Treatment Diabetic Retinopathy Study: ETDRS report number 17. Ophthalmology 99:1351-1357.
10. v integrins. Science 270:1500-1502.
11. Hammes H, Brownlee M, Jonczyk A, Sutter A, and Preissner K (1996). Subcutaneous injection of a cyclic peptide antagonist of vitronectin receptor-type integrins inhibits retinal neovascularization. Nat Med 2:529-533.
12. Hunter D and Mukai S (1992). Retinopathy of prematurity: Pathogenesis, diagnosis, and treatment. Int Ophthalmol Clin 32:163-184.
13. Hynes R (1992). Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 69:11-25.
14. Kahn HA and Miller R (1974). Blindness caused by diabetic retinopathy. Am J Ophthalmol 78:58-67.
15. McDonald H and Schatz H (1985). Visual loss following panretinal photocoagulation for proliferative diabetic retinopathy. Ophthalmology 92:388-393.
16. Miller J, Adamis A, Shima D, D'Amore P, Molton R, O'Reilly M, Folkman J, Dvorak H, Brown L, Berse B, Yeo T, and Yeo K (1994). Vascular endothelial growth factor/vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in a primate model. Am J Pathol 145:574-584.
17. Mousa S, Bozarth J, Forsythe M, Lorelli W, Thoden M, Ramachandran N, Jackson S, DeGrado W, and Reilly T (1993). Antiplatelet efficacy and specificity of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist. Cardiology 83: 374-382.
18. Mousa S, DeGrado W, Mu D, Kapil R, Lucchesi B, and Reilly T (1996). Oral antiplatelet, antithrombotic efficacy of a novel orally active platelet GPIIb/IIIa antagonist, DMP728 in dogs. Circulation 93:537-543.
19. O'Neil K, DeGrado W, Mousa S, Ramachandran N, and Hoess R (1994). Identification of recognition sequences of adhesion molecules using phage display technology. Methods Enzymol 245:370-386.
20. Pierce E, Avery R, Foley E, Aiello L, and Smith L (1995). Vascular endothelial growth factor factor/vascular permeability factor expression in a mouse model of retinal neovascularization. Proc Natl Acad Sci USA 92:905-909.
21. Plate K, Breier G, Welch H, and Risau W (1992). Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature 359:845-848.
22. Porter G, Palade G, and Milici A (1990). Differential binding of the lectins griffonia simplicifolia I and lycopersicon esculentum to microvascular endothelium: Organ-specific localization and partial glycoprotein characterization. Eur J Cell Biol 51:85-95.
23. Pournaras C, Tsacopoulos M, Strommer K, Gilodi N, and Leuenberger P (1990). Scatter photocoagulation restores tissue hypoxia in experimental vasoproliferative microangiopathy in miniature pigs. Ophthalmology 97:1329-1333.
24. Shweiki D, Itin A, Soffer D, and Keshet E (1992). Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 359:843-845.
25. Sivalingam A, Kenney J, Brown G, Benson W, and Donoso L (1990). Basic fibroblast growth factor levels in the vitreous of patients with proliferative diabetic retinopathy. Arch Ophthalmol 108:869-872.
26. Smith L, Wesolowski E, McLellan A, Kostyk S, D'Amato R, Sullivan R, and D'Amore P (1994). Oxygen-induced retinopathy in the mouse. Invest Ophthalmol Vis Sci 35:101-111.
27. Stone J, Itin A, Alon T, Pe'er J, Gnessin H, Chen-Ling T, and Keshet E (1995). Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci 15:4738-4747.
28. Vinores S, Henderer J, Mahlow J, Chiu C, Derevjanik N, LaRochelle W, Csaky C, and Campochiaro P (1994). Isoforms of platelet-derived growth factor and its receptors in epiretinal membranes: Immunolocalization to retinal pigmented epithelial cells. Exp Eye Res 60:607-619.